Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Emily McCusker"'
1
Akademický článek
High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study
Autor: Gerard E. Francisco, Daniel S. Bandari, Ganesh Bavikatte, Wolfgang H. Jost, Emily McCusker, Joan Largent, Aleksej Zuzek, Alberto Esquenazi
Publikováno v: Toxicon: X, Vol 7, Iss , Pp 100040- (2020)
Etiology-specific onabotulinumtoxinA utilization to manage spasticity is largely unknown. In this 1-year interim analysis, we evaluated real-world onabotulinumtoxinA utilization and effectiveness across several etiologies from the Adult Spasticity In
Externí odkaz: https://doaj.org/article/d5c3181fa04645848812ae2c272c4d98
Zobrazit plný text záznamu
3
Efficacy and safety of onabotulinumtoxinA with standardized physiotherapy for the treatment of pediatric lower limb spasticity: A randomized, placebo-controlled, phase III clinical trial
Autor: Rozalina Dimitrova, Heakyung Kim, Jill Meilahn, Henry G. Chambers, Brad A. Racette, Marcin Bonikowski, Eun Sook Park, Emily McCusker, Chengcheng Liu, Mitchell F. Brin
Publikováno v: NeuroRehabilitation, vol 50, iss 1
BACKGROUND: Spasticity is common in cerebral palsy and can result in pain and diminished health-related quality of life. OBJECTIVE: To evaluate the safety and efficacy of onabotulinumtoxinA for lower limb spasticity treatment in children with cerebra
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5afcfebd70795803f5f8512ec3d8bbb
https://doi.org/10.3233/nre-210070
Zobrazit plný text záznamu
4
Efficacy and safety of onabotulinumtoxinA with standardized occupational therapy for treatment of pediatric upper limb spasticity: Phase III placebo-controlled randomized trial
Autor: Chengcheng Liu, Rozalina Dimitrova, Emily McCusker, Mark Gormley, Mitchell F. Brin, Darcy Fehlings, Katharine E. Alter, Susan Greaves
Publikováno v: Neurorehabilitation
BACKGROUND: This is the first large study of onabotulinumtoxinA as treatment for pediatric upper limb spasticity. OBJECTIVE: Evaluate efficacy and safety of a single treatment with onabotulinumtoxinA plus occupational therapy (OT). METHODS: In this r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f548736e08fb17c60482f0c41b270d9d
https://doi.org/10.3233/nre-210071
Zobrazit plný text záznamu
5
A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up
Autor: Robert L. Findling, Emily McCusker, Jeffrey R. Strawn
Publikováno v: Journal of Child and Adolescent Psychopharmacology
Objective: To evaluate the efficacy and long-term safety of vilazodone in children and adolescent outpatients with major depressive disorder (MDD). Methods: Children and adolescents aged 7–17 years of age with MDD were randomized 2:2:1 to 8 weeks o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1010e1e3d6e20d801eee28fc601eb531
https://doi.org/10.1089/cap.2019.0176
Zobrazit plný text záznamu
6
High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study
Autor: Alberto Esquenazi, Daniel S. Bandari, Aleksej Zuzek, Gerard E. Francisco, Emily McCusker, Ganesh Bavikatte, Wolfgang H. Jost, Joan Largent
Publikováno v: Toxicon: X
Toxicon: X, Vol 7, Iss, Pp 100040-(2020)
Etiology-specific onabotulinumtoxinA utilization to manage spasticity is largely unknown. In this 1-year interim analysis, we evaluated real-world onabotulinumtoxinA utilization and effectiveness across several etiologies from the Adult Spasticity In
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::233dc08141484f2c6aed050fc41d89bd
http://europepmc.org/articles/PMC7452133
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje